Establishing Monoclonal Gammopathy of Undetermined Significance as an Independent Pre-Disease State of Multiple Myeloma Using Raman Spectroscopy, Dynamical Network Biomarker Theory, and Energy Landscape Analysis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25031570 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Shota Yonezawa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Pre-Disease Science, University of Toyama, Toyama 930-8555, Japan. Hauptthemen laut MEDLINE: Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Paraproteinemias. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency, JST Moonshot.
Abstract (Originalsprache)
Multiple myeloma (MM) is a cancer of plasma cells. Normal (NL) cells are considered to pass through a precancerous state, such as monoclonal gammopathy of undetermined significance (MGUS), before transitioning to MM. In the present study, we acquired Raman spectra at three stages—834 NL, 711 MGUS, and 970 MM spectra—and applied the dynamical network biomarker (DNB) theory to these spectra. The DNB analysis identified MGUS as the unstable pre-disease state of MM and extracted Raman shifts at 1149 and 1527–1530 cm−1 as DNB variables. The distribution of DNB scores for each patient showed a significant difference between the mean values for MGUS and MM patients. Furthermore, an energy landscape (EL) analysis showed that the NL and MM stages were likely to become stable states. Raman spectroscopy, the DNB theory, and, complementarily, the EL analysis will be applicable to the identification of the pre-disease state in clinical samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center for Pre-Disease Science, University of Toyama, Toyama 930-8555, Japan.
- Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan.
- Faculty of Sustainable Design, University of Toyama, Toyama 930-8555, Japan.
- Division of Presymptomatic Disease, Institute of Natural Medicine, University of Toyama, Toyama 930-0194, Japan.
- Faculty of Engineering, University of Toyama, Toyama 930-8555, Japan.
- Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.
ORCID-Profile: Shota Yonezawa, Takayuki Haruki, Keiichi Koizumi, Akinori Taketani, Yusuke Oshima, Makito Oku, Akinori Wada, Tsutomu Sato, Naoki Masuda, Makoto Kadowaki, Isao Kitajima, Shigeru Saito
Förderung
- Japan Science and Technology Agency
- JST Moonshot
Zitieren
APA
Yonezawa, S., Haruki, T., Koizumi, K., Taketani, A., Oshima, Y., Oku, M., Wada, A., Sato, T., Masuda, N., Tahara, J., Fujisawa, N., Koshiyama, S., Kadowaki, M., Kitajima, I., & Saito, S. (2024). Establishing Monoclonal Gammopathy of Undetermined Significance as an Independent Pre-Disease State of Multiple Myeloma Using Raman Spectroscopy, Dynamical Network Biomarker Theory, and Energy Landscape Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031570
Vancouver
Yonezawa S, Haruki T, Koizumi K, Taketani A, Oshima Y, Oku M, et al. Establishing Monoclonal Gammopathy of Undetermined Significance as an Independent Pre-Disease State of Multiple Myeloma Using Raman Spectroscopy, Dynamical Network Biomarker Theory, and Energy Landscape Analysis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031570
BibTeX
@article{Yonezawa2024,
author = {Yonezawa, Shota and Haruki, Takayuki and Koizumi, Keiichi and Taketani, Akinori and Oshima, Yusuke and Oku, Makito and Wada, Akinori and Sato, Tsutomu and Masuda, Naoki and Tahara, Jun and Fujisawa, Noritaka and Koshiyama, Shota and Kadowaki, Makoto and Kitajima, Isao and Saito, Shigeru},
title = {Establishing Monoclonal Gammopathy of Undetermined Significance as an Independent Pre-Disease State of Multiple Myeloma Using Raman Spectroscopy, Dynamical Network Biomarker Theory, and Energy Landscape Analysis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25031570}
}
EUVIMED